Goldman Sachs Group Inc Immuneering Corp Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Immuneering Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 741,548 shares of IMRX stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

741,548

Previous 454,233 63.25%

Holding current value

$1.38 Million

Previous $1.31 Million 27.67%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.28 - $2.75 $367,763 - $790,116	287,315 Added 63.25%	741,548 $949,000
Q1 2024 May 15, 2024	SELL	$1.91 - $7.32 $5,397 - $20,686	-2,826 Reduced 0.62%	454,233 $1.31 Million
Q4 2023 Feb 13, 2024	SELL	$4.84 - $8.44 $125,215 - $218,351	-25,871 Reduced 5.36%	457,059 $3.36 Million
Q3 2023 May 14, 2024	BUY	$7.21 - $10.68 $186,529 - $276,302	25,871 Added 5.66%	482,930 $3.71 Million
Q3 2023 Nov 14, 2023	SELL	$7.21 - $10.68 $42,776 - $63,364	-5,933 Reduced 1.21%	482,930 $3.71 Million
Q2 2023 May 14, 2024	BUY	$6.49 - $13.36 $3 Million - $6.18 Million	462,652 Added 1765.11%	488,863 $4.96 Million
Q2 2023 Aug 14, 2023	BUY	$6.49 - $13.36 $3 Million - $6.18 Million	462,652 Added 1765.11%	488,863 $4.96 Million
Q1 2023 May 14, 2024	BUY	$3.78 - $10.38 $60,230 - $165,394	15,934 Added 155.05%	26,211 $254,000
Q1 2023 May 11, 2023	BUY	$3.78 - $10.38 $60,230 - $165,394	15,934 Added 155.05%	26,211 $254,000
Q4 2022 May 14, 2024	SELL	$4.09 - $15.0 $6,343 - $23,265	-1,551 Reduced 13.11%	10,277 $49,000
Q4 2022 Feb 13, 2023	SELL	$4.09 - $15.0 $6,343 - $23,265	-1,551 Reduced 13.11%	10,277 $49,000
Q3 2022 May 14, 2024	SELL	$5.0 - $14.32 $33,780 - $96,745	-6,756 Reduced 36.35%	11,828 $169,000
Q3 2022 Nov 10, 2022	SELL	$5.0 - $14.32 $33,780 - $96,745	-6,756 Reduced 36.35%	11,828 $0
Q2 2022 May 14, 2024	SELL	$3.89 - $7.81 $1.71 Million - $3.42 Million	-438,475 Reduced 95.93%	18,584 $101,000
Q2 2022 Aug 15, 2022	BUY	$3.89 - $7.81 $13,723 - $27,553	3,528 Added 23.43%	18,584 $101,000
Q1 2022 May 16, 2022	BUY	$6.47 - $16.99 $12,254 - $32,179	1,894 Added 14.39%	15,056 $97,000
Q4 2021 Feb 14, 2022	BUY	$16.12 - $31.02 $212,171 - $408,285	13,162 New	13,162 $213,000

Others Institutions Holding IMRX

# of Institutions

Shares Held

9.63M

Call Options Held

Put Options Held

View Full List

About Immuneering Corp

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $49.1M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

More about IMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Immuneering Corp Transaction History